Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc.
| Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc. |
| Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. |
| 1:2021cv01001 |
| July 7, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 30, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re (D.I. 18 in 21-cv-1000-RGA; D.I. 17 in 21-cv-1001-RGA; D.I. 19 in 21-cv-314-RGA; D.I. 14 in 21-cv-732-RGA) MOTION for Pro Hac Vice Appearance of Attorney Thomas D. Rein and Andrew T. Langford, filed by Janssen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms)
|
| Filing 17 MOTION for Pro Hac Vice Appearance of Attorney Thomas D. Rein and Andrew T. Langford - filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
|
Filing 16
SO ORDERED Granting #14 Stipulation Dismissal Teva Pharmaceutical Industries, Ltd. (*Party Teva Pharmaceutical Industries Ltd. terminated). Signed by Judge Richard G. Andrews on 8/23/2021. (nms)
|
| Pro Hac Vice Attorneys Brady P. Gleason, Chandrika Vira, J.C. Rozendaal for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
|
SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal and Chandrika Vira, filed by Teva Pharmaceuticals USA, Inc., and #15 MOTION for Pro Hac Vice Appearance of Attorney Brady P. Gleason, filed by Teva Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 8/23/2021. (nms)
|
| Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Brady P. Gleason - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Filing 14 STIPULATION of Dismissal, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/21/2021 (nms). |
| Filing 13 MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal and Chandrika Vira - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Filing 11 ANSWER to #1 Complaint, and COUNTERCLAIMS against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) Modified on 8/23/2021 (nms). |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Dov P. Grossman, Alexander S. Zolan, Kathryn S. Kayali, and Julie L. Tavares - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
|
SO ORDERED, re (D.I. 16 in 21-cv-1000-RGA; D.I. 12 in 21-cv-732-RGA; D.I. 10 in 21-cv-1001-RGA) MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Dov P. Grossman, Alexander S. Zolan, Kathryn S. Kayali, and Julie L. Tavares, filed by Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Bayer AG. Signed by Judge Richard G. Andrews on 8/11/2021. Associated Cases: 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms)
|
|
SO ORDERED, re #9 STIPULATION to Extend Time (*Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 8/19/2021). Signed by Judge Richard G. Andrews on 7/30/2021. (nms)
|
| Filing 9 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond the Complaint to August 19, 2021 - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:21-cv-01000-RGA, 1:21-cv-01001-RGA (rjb) |
| Filing 8 SUMMONS Returned Executed by Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Bayer AG. Teva Pharmaceuticals USA, Inc. served on 7/8/2021, answer due 7/29/2021. (Fahnestock, Derek) |
| Filing 7 Summonses Issued (please complete the top portion of the form and print out for use/service). (twk) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (twk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer Pharma AG. (twk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (twk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/16/2021. Date of Expiration of Patent: 1/31/2039. Thirty Month Stay Deadline: N/A. (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3652716.) - filed by Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Bayer AG. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
